Improving heart health in Haiti
Welcome to HAITI CVD COLLABORATORY
Our Mission
The HAITI CVD Collaboratory brings together researchers, clinicians, community partners, and public health leaders dedicated to understanding and reducing the burden of cardiovascular disease (CVD) in low‑resource settings. Our mission is to generate high‑quality, population-based evidence that can directly improve clinical care, inform policy, and strengthen health systems in Haiti and similar settings of severe poverty, including in the US, disproportionately affected by cardiovascular disease.
Our Collaboration
This network generates actionable research to improve cardiovascular disease outcomes, share best practices, and build local capacity and infrastructure. Our work is led by GHESKIO (the French acronym for the Haitian Group for the Study of Kaposi Sarcoma and Opportunistic Infections), which was founded by Dr. Bill Pape in 1982 as a non-profit clinical organization to provide treatment, training, research, and social services in Haiti. GHESKIO has never closed its doors despite natural disasters, pandemics, and political unrest. Currently, it provides care to more than 100,000 patients annually. The network includes community stakeholders, national leaders and policy makers, and collaborations with academic institutions.
We are committed to building local capacity through mentorship, clinical training, and collaborative learning. Our initiatives support Haitian and US clinicians, emerging researchers, and international trainees through hands-on field experiences, skills-building in methods including epidemiology and implementation science, training in cardiovascular imaging, and clinical training. Our collaboration helped develop and disseminate the national Primary Care Hypertension Guidelines across GHESKIO clinics, ensuring that new evidence drives improved care and strengthens the foundation for the next generation of cardiovascular health leaders.